Cargando…
The role of Rezum in the management of refractory urinary retention due to benign prostate hyperplasia: A literature review
BACKGROUND: Benign prostatic hyperplasia is the most common cause of urinary retention in men (BPH). The gold standard surgical treatment is transurethral resection of the prostate (TURP). However, due to the morbidity and mortality associated with TURP, more minimally invasive treatments, such as v...
Autores principales: | Khalil, Ibrahim A., Aldeeb, Maya, Mohammed, Ahmed, Awad, Khalid, Ibrahim, Tarek, Al-Zoubi, Raed M., Aboumarzouk, Omar M, Al-Rumaihi, Khalid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373601/ https://www.ncbi.nlm.nih.gov/pubmed/37521455 http://dx.doi.org/10.1080/2090598X.2023.2178104 |
Ejemplares similares
-
Oral desmopressin in nocturia with benign prostatic hyperplasia: A systematic review of the literature
por: Taha, Diaa-Eldin, et al.
Publicado: (2018) -
Shared Inherited Genetics of Benign Prostatic Hyperplasia and Prostate Cancer
por: Glaser, Alexander, et al.
Publicado: (2022) -
Transperineal intraprostatic injection of botulinum neurotoxin A vs transurethral resection of prostate for management of lower urinary tract symptoms secondary to benign prostate hyperplasia: A prospective randomised study
por: El-Dakhakhny, Amr S., et al.
Publicado: (2019) -
Simultaneous antegrade and retrograde endoscopic surgery for benign prostatic hyperplasia with vesical calculi – A single-centre experience
por: Javali, Tarun, et al.
Publicado: (2018) -
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30–80-cm(3) and 80–150-cm(3) Prostates
por: Nguyen, David-Dan, et al.
Publicado: (2021)